Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Diane L. McNally"'
Autor:
Amy J. Davidoff, Sheila Weiss Smith, Maria R. Baer, Xuehua Ke, Jason M. Bierenbaum, Franklin Hendrick, Diane L. McNally, Steven D. Gore
Publikováno v:
Haematologica, Vol 97, Iss 1 (2012)
Patient and physician characteristics associated with use of erythropoiesis-stimulating agents in myelodysplastic syndrome patients have not yet been described. Myelodysplastic syndrome patients diagnosed from 2001 to 2005 were identified from the Su
Externí odkaz:
https://doaj.org/article/083819a64ecc4ba3aa62450bf5993be3
Autor:
Eberechukwu Onukwugha, Brian S. Seal, C. Daniel Mullins, Arif Hussain, Diane L. McNally, Candice Yong
Publikováno v:
Journal of Geriatric Oncology. 5:281-289
Objective Skeletal-related events (SREs) are defined as a cluster of events including clinical diagnoses and treatment. Using claims data, the burden of SREs as a group has been reported among patients with cancer. We investigate the mortality impact
Autor:
Maria R. Baer, Amy J. Davidoff, Dalia Mahmoud, Steven D. Gore, Diane L. McNally, Franklin Hendrick, Amer M. Zeidan
Publikováno v:
Cancer. 119:3870-3878
BACKGROUND Lenalidomide is approved for the treatment of anemia with transfusion dependence (TD) in patients with lower-risk myelodysplastic syndrome (MDS) with 5q deletion (del5q-MDS), but its “real-life” use and effect on transfusion needs are
Autor:
James Bethel, Debra E. Irwin, Julie M. Zito, Norma I. Gavin, James Korelitz, Donald R. Mattison, Kelly J. Kelleher, Judith D. Rubin, Yiling Xu, Mary N. Masters, Diane L. McNally
Publikováno v:
Annals of Allergy, Asthma & Immunology. 100:222-229
Background Asthma is one of the most common chronic conditions in children and has a major impact on health care use and quality of life. The Best Pharmaceuticals for Children Act mandates the federal government to sponsor pediatric studies of drugs
Publikováno v:
American Journal of Health-System Pharmacy. 61:2410-2414
ILENE H. ZUCKERMAN, PHARM.D., is Associate Professor and MIKHAIL MENIS, PHARM.D., M.S., is Graduate Research Assistant, Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland (UM), Baltimore. DIANE L. MCNALLY,
Publikováno v:
Annals of Pharmacotherapy. 38:961-966
BACKGROUND:The 1990 Omnibus Budget Reconciliation Act mandated drug utilization review in response to inappropriate drug use. In the Pennsylvania Medicaid program, pediatric asthma is associated with high healthcare utilization and cost.OBJECTIVE:To
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 23(6)
Population-based estimates of the prevalence of thyrotoxicosis (TTX), the frequency of antithyroid drug (ATD) use, and risk of adverse events in pregnant women and their infants are lacking. Therefore, our objective was to obtain epidemiologic estima
Autor:
Nader Hanna, Diane L. McNally, Nneka C. Onwudiwe, Mehul Dalal, Kaloyan A. Bikov, C. Daniel Mullins
Publikováno v:
The oncologist. 17(9)
Learning Objectives After completing this course, the reader will be able to: Identify the prevalence of adjuvant chemotherapy utilization in elderly patients with stage III colon cancer.Discuss the prevalence and impact of venous thromboembolism in
Autor:
Jason Bierenbaum, Steven D. Gore, Diane L. McNally, Maria R. Baer, Franklin Hendrick, Xuehua Ke, Sheila Weiss Smith, Amy J. Davidoff
Publikováno v:
Haematologica. 97(1)
Patient and physician characteristics associated with use of erythropoiesis-stimulating agents in myelodysplastic syndrome patients have not yet been described. Myelodysplastic syndrome patients diagnosed from 2001 to 2005 were identified from the Su
Autor:
Sheila Weiss Smith, Steven D. Gore, Diane L. McNally, Amy J. Davidoff, Masayo Sato, Xuehua Ke, Maria R. Baer
Publikováno v:
Haematologica. 97(1)
Background There are limited reports of thrombosis among myelodysplastic syndrome patients exposed to erythropoiesis stimulating agents. It is not clear whether erythropoiesis stimulating agents are associated with an increased risk of thrombosis in